Cambridge Advisors Inc. Has $1.07 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Cambridge Advisors Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.4% in the 4th quarter, HoldingsChannel reports. The firm owned 2,122 shares of the healthcare conglomerate’s stock after selling 685 shares during the period. Cambridge Advisors Inc.’s holdings in UnitedHealth Group were worth $1,073,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of UNH. Pacer Advisors Inc. lifted its position in UnitedHealth Group by 5.7% during the 2nd quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock worth $33,540,000 after buying an additional 3,525 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its stake in shares of UnitedHealth Group by 3.4% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 700,864 shares of the healthcare conglomerate’s stock valued at $356,922,000 after purchasing an additional 23,129 shares during the last quarter. ProShare Advisors LLC lifted its holdings in UnitedHealth Group by 7.9% during the 2nd quarter. ProShare Advisors LLC now owns 245,171 shares of the healthcare conglomerate’s stock worth $124,856,000 after buying an additional 17,861 shares in the last quarter. Frank Rimerman Advisors LLC raised its position in shares of UnitedHealth Group by 61,354.2% during the second quarter. Frank Rimerman Advisors LLC now owns 14,749 shares of the healthcare conglomerate’s stock worth $7,511,000 after acquiring an additional 14,725 shares during the last quarter. Finally, 1832 Asset Management L.P. increased its position in UnitedHealth Group by 12.0% in the second quarter. 1832 Asset Management L.P. now owns 1,797,607 shares of the healthcare conglomerate’s stock worth $915,449,000 after purchasing an additional 192,128 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of recent research reports. Truist Financial dropped their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, January 15th. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Stephens boosted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Stock Performance

Shares of UNH opened at $510.03 on Monday. The firm has a fifty day simple moving average of $549.37 and a 200 day simple moving average of $563.18. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market capitalization of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company earned $5.83 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.